MedTrace Logo

Promising Bimarker Prediction of Outcome of HELLP Syndrome.

NCT03246542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-08-11

No results posted yet for this study

Summary

HELLP syndrome is a life-threatening obstetric complication usually considered to be a variant or complication of pre-eclampsia. And may occasionally be confused with other diseases complicating pregnancy such as acute fatty liver of pregnancy, gastroenteritis, hepatitis, appendicitis, gallbladder disease, immune thrombocytopenia, lupus flare, antiphospholipid syndrome, hemolytic-uremic syndrome, thrombotic thrombocytopenic purpura, and nonalcoholic fatty liver disease. The distinction between thrombotic thrombocytopenic purpura-hemolytic uremic syndrome and severe preeclampsia is important for therapeutic and prognostic reasons. However, the clinical and histological features are so similar that establishing the correct diagnosis is often difficult; furthermore, these disorders may occur concurrently.

Conditions

  • Pre-Eclampsia, Severe
  • HELLP Syndrome
  • Microangiopathy

Interventions

DIAGNOSTIC_TEST

shistocytes percentage

Sponsors & Collaborators

  • AYMAN ABDELKADER MOHAMED ABDELKADER

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2015-12-01
Completion
2016-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03246542 on ClinicalTrials.gov